From: Prognostic and predictive value of cathepsin X in serum from colorectal cancer patients
Median | Mean | SD | Minimum | Lower Quartile | Upper Quartile | Maximum | |
---|---|---|---|---|---|---|---|
(ng/ml) | (ng/ml) | (ng/ml) | (ng/ml) | (ng/ml) | (ng/ml) | (ng/ml) | |
All samples | 23.2 | 23.4 | 6.4 | 8.7 | 19.1 | 27.3 | 47.1 |
Stagea | p = 0.76 | ||||||
I | 23.4 | 24.7 | 7.4 | 12.6 | 20.3 | 28.5 | 44.5 |
II | 23.4 | 22.9 | 5.6 | 10.9 | 18.6 | 26.6 | 35.4 |
III | 22.4 | 22.8 | 6.4 | 8.7 | 19.1 | 27.5 | 38.1 |
IV | 22.9 | 23.5 | 6.6 | 10.4 | 18.5 | 27.4 | 47.1 |
Cancer localisation | p = 0.36 | ||||||
Left-sided colon cancer | 23.3 | 24.2 | 6.0 | 12.3 | 20.1 | 27.8 | 40.0 |
Right-sided colon cancer | 22.9 | 22.5 | 6.5 | 8.7 | 16.6 | 27.3 | 38.1 |
Rectal cancer | 23.0 | 23.3 | 6.6 | 9.5 | 18.7 | 26.3 | 47.1 |
Gender | p = 0.49 | ||||||
Female | 23.3 | 23.9 | 6.2 | 11.8 | 19.2 | 27.4 | 44.5 |
Male | 23.1 | 23.1 | 6.4 | 8.7 | 18.9 | 26.9 | 47.1 |